Therapeutic efficacy of alpha-1 antitrypsin augmentation therapy on the loss of lung tissue: an integrated analysis of 2 randomised clinical trials using computed tomography densitometry

[1]  R. Riley,et al.  Meta-analysis of individual participant data: rationale, conduct, and reporting , 2010, BMJ : British Medical Journal.

[2]  A. Dirksen,et al.  Exploring the role of CT densitometry: a randomised study of augmentation therapy in α1-antitrypsin deficiency , 2009, European Respiratory Journal.

[3]  R. Stockley,et al.  Rate of progression of lung function impairment in α1-antitrypsin deficiency , 2009, European Respiratory Journal.

[4]  Tasha R. Stanton,et al.  Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review , 2008, Physical Therapy.

[5]  R. Stockley,et al.  Radiologic and clinical features of copd patients with discordant pulmonary physiology - Lessons from α-1 antitrypsin deficiency. , 2007, Revista portuguesa de pneumologia.

[6]  R. Stockley,et al.  Radiologic and clinical features of COPD patients with discordant pulmonary physiology: lessons from alpha1-antitrypsin deficiency. , 2007, Chest.

[7]  Panos Kanavos,et al.  Assessing the economic challenges posed by orphan drugs , 2007, International Journal of Technology Assessment in Health Care.

[8]  David Handelsman,et al.  Rate, extent, and modifiers of spermatogenic recovery after hormonal male contraception: an integrated analysis , 2006, The Lancet.

[9]  B C Stoel,et al.  Validation of computed tomographic lung densitometry for monitoring emphysema in α1-antitrypsin deficiency , 2006, Thorax.

[10]  D. Postma,et al.  Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease , 2005, Thorax.

[11]  A. Dirksen,et al.  American Thoracic Society/European Respiratory Society: Standards in Diagnostik und Therapie bei Patienten mit Alpha-1-Antitrypsin-Mangel , 2005 .

[12]  Jan Stolk,et al.  Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment. , 2004, American journal of respiratory and critical care medicine.

[13]  J. Stoller.  Erratum: ATS/ERS Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency (American Journal of Respiratory and Critical Care Medicine (835)) , 2004 .

[14]  R. Stockley,et al.  Predictors of mortality in α1-antitrypsin deficiency , 2003, Thorax.

[15]  A. Dirksen,et al.  Standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency: Executive summary , 2003 .

[16]  R. Stockley,et al.  High-resolution computed tomography scanning in α1-antitrypsin deficiency: relationship to lung function and health status , 2001 .

[17]  R. Stockley,et al.  Exercise capacity predicts health status in α1-Antitrypsin deficiency , 2001 .

[18]  R. Stockley,et al.  Exercise capacity predicts health status in alpha(1)-antitrypsin deficiency. , 2001, American journal of respiratory and critical care medicine.

[19]  M. Schluchter,et al.  Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group. , 2000, American journal of respiratory and critical care medicine.

[20]  M. Schluchter,et al.  Feasibility of a Clinical Trial of Augmentation Therapy for α1-Antitrypsin Deficiency , 2000 .

[21]  H A Vrooman,et al.  A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. , 1999, American journal of respiratory and critical care medicine.

[22]  R. S. Sen,et al.  Survival and FEV1 decline in individuals with severe deficiency of α1-antitrypsin , 1998 .

[23]  N. Banik,et al.  Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group. , 1997, The European respiratory journal.

[24]  Lene Theil Skovgaard,et al.  Progress of emphysema in severe α1-Antitrypsin Deficiency as Assessed by Annual CT , 1997 .

[25]  A. Dirksen,et al.  Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. , 1997, Acta radiologica.

[26]  V M Hawthorne,et al.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study , 1996, BMJ.

[27]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[28]  E. Wouters,et al.  Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. , 1996, Thorax.

[29]  E. Wouters,et al.  DETERMINANTS OF HEALTHRELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE , 1996 .

[30]  E. Vittinghoff,et al.  Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. , 1995, JAMA.

[31]  M. Parmar,et al.  Meta-analysis of the literature or of individual patient data: is there a difference? , 1993, The Lancet.

[32]  G Gamsu,et al.  High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity. , 1992, Radiology.

[33]  R. Crystal,et al.  Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema. , 1987, The New England journal of medicine.

[34]  G. Snider,et al.  Emphysema and bronchial secretory cell metaplasia induced in hamsters by human neutrophil products. , 2015, The American review of respiratory disease.

[35]  A. E. Anderson,et al.  Small airways in severe panlobular emphysema: mural thickening and premature closure. , 2015, The American review of respiratory disease.

[36]  B. Burrows.  A clinical trial of efficacy of antiproteolytic therapy: can it be done? , 2015, The American review of respiratory disease.